.Novo Nordisk has axed its once-monthly dual GLP-1/ GIP receptor agonist, finishing (PDF) progressio...
.Merck & Co. has promptly gotten back several of the prices of its Harpoon Therapies buyout, attr...
.After BioMarin carried out a spring season clean of its pipeline in April, the company has decided ...
.Major Pharmas remain stuck to the idea of molecular glue degraders. The latest firm to see an optio...
.A brand new worldwide life scientific research credit history organization, referred to as Symbioti...
.Bristol Myers Squibb is actually axing an additional large wager from the Caforio period, canceling...
.After looking at phase 1 data, Nuvation Bio has chosen to stop deal with its single top BD2-selecti...
.Zevra Rehabs' uncommon illness medicine seems to be to be on the pathway to authorization this fall...
.Pfizer's period 3 Duchenne muscular dystrophy (DMD) gene treatment failing has blown a $230 thousan...
.After greater than two decades of work with neurodegenerative illness, Swiss biotech air conditioni...